TLPO-001

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameTLPO-001

Drug Alias NameTLPO-001

ClassificationVaccines > Development/production technology > Dendritic cell vaccineCell and gene therapy > Cell therapy > Immune system cell therapy > Dendritic cell therapy > Dendritic cell vaccine

Mechanisms of ActionWilms' Tumour 1 modulators

TargetsWilms' Tumour 1

Therapy Area/IndicationsPancreatic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPhase 3 Clinical

Highest Status in ChinaN/A

Originator CompaniesTella Wakayama Medical University

China Registration ClassN/A

Develop Information

Active CompaniesTella Wakayama Medical University

Inactive CompaniesN/A

Active IndicationsPancreatic Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A